Actuate Therapeutics IncACTUNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P10
Near historical low
vs 2Y Ago
-1x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -21.23% |
| Q2 2025 | -14.14% |
| Q1 2025 | -12.63% |
| Q4 2024 | -1.89% |
| Q3 2024 | -14.08% |
| Q2 2024 | -36.26% |
| Q1 2024 | 3.23% |
| Q4 2023 | 15.35% |
| Q3 2023 | 20.60% |
| Q2 2023 | 5.60% |
| Q1 2023 | 0.00% |